Results 131 to 140 of about 225,886 (256)

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant   +11 more
wiley   +1 more source

Distal Coronary Artery Thrombus After Primary PCI Resolved by Excimer Laser Coronary Angioplasty. [PDF]

open access: yesJACC Case Rep
Mori T   +9 more
europepmc   +1 more source

Restoring Fashion History

open access: yes, 2023
Pouillard, Veronique   +2 more
openaire   +1 more source

The fashion rhizome: an alternate view of fashion history and education [PDF]

open access: yes
Our idea for the Fashion Colloquia Milano is to present the concept of ‘the fashion rhizome’. We want to open up a discussion about design education and fashion history by exploring a theory that encourages creative, lateral and fluid thinking. Our proposal builds on our previous experiences when engaging with presenting fashion histories. We will also
Hunt, KJ, Trew, Y
openaire  

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Combined robot-assisted simple prostatectomy and laparoscopic nephrectomy: a case series. [PDF]

open access: yesJ Med Case Rep
Khanmammadova N   +10 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Successful Maternal-Assisted Cesarean Using a Modified Australian Protocol. [PDF]

open access: yesCase Rep Obstet Gynecol
Lamoutte C   +6 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

open access: yesMolecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy